Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Share-based Compensation (2020 - 2025)

Vivos Therapeutics has reported Share-based Compensation over the past 6 years, most recently at $47000.0 for Q4 2025.

  • Quarterly Share-based Compensation changed N/A to $47000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $764000.0 through Dec 2025, down 90.56% year-over-year, with the annual reading at $661000.0 for FY2025, 5909.09% up from the prior year.
  • Share-based Compensation was $47000.0 for Q4 2025 at Vivos Therapeutics, down from $100000.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $7.5 million in Q2 2024 and troughed at $47000.0 in Q4 2025.
  • The 5-year median for Share-based Compensation is $400000.0 (2022), against an average of $788947.4.
  • Year-over-year, Share-based Compensation soared 1775.0% in 2024 and then tumbled 96.0% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $463000.0 in 2021, then soared by 67.39% to $775000.0 in 2022, then crashed by 81.16% to $146000.0 in 2023, then surged by 105.48% to $300000.0 in 2024, then crashed by 84.33% to $47000.0 in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Share-based Compensation are $47000.0 (Q4 2025), $100000.0 (Q3 2025), and $300000.0 (Q2 2025).